ENTITY
Aurobindo Pharma

Aurobindo Pharma (ARBP IN)

137
Analysis
Health Care • India
Aurobindo Pharma Limited manufactures and markets oral and sterile antibiotics, antibacterials, anti-ulcerants and other generic basic drugs. Products include semi-synthetic penicillin drugs like ampicillin and amoxycillinas well as antibiotics, which include cloxacillin and dicloxacillin. The Company also manufactures formulations like astemizole, domeperidone and omeprazole.
more
•29 May 2025 01:20•Broker

HSIE Results Daily: Infoedge, Aurobindo Pharma, KEC International, TTK Prestige, Stylam Industries

Infoedge reported strong billings growth, but the margins were impacted due to higher investments. Info Edge's recruitment business billings were...

Logo
267 Views
Share
•14 May 2025 19:34•Broker

Pharmaceuticals: US to cut Rx drug price, no impact on generics

The US president Donald Trump signed an “Executive Order” (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations

Logo
163 Views
Share
•04 Apr 2025 05:28•Broker

Pharmaceuticals: Pharma dodges first round of US tariff risk

The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India

Logo
213 Views
Share
•15 Jan 2025 21:37•Broker

Pharma and Healthcare (Q3FY25E): Growth Momentum, Margin Visibility Stay Intact

The India Pharma & Healthcare sector is expected to see steady growth in Q3FY25E. We project sales/EBITDA growth of 11%/13% YoY for our coverage...

Logo
327 Views
Share
•03 Dec 2024 07:42•Broker

Axis Top Picks for the Month of December 2024

Axis Top Picks Basket delivered a return of 10.9% in the last six months against the 7.1% returns posted by Nifty 50 over the same period.

Logo
434 Views
Share
x